Back to Top
Charles H. Hood Foundation | New PRI Funding Collaboration
By identifying innovative pediatric advancements and providing funding in the critical phases of development, we are able to expedite high-impact breakthroughs that improve the health and lives of millions.
18120
post-template-default,single,single-post,postid-18120,single-format-standard,ajax_fade,page_not_loaded,,no_animation_on_touch,qode-title-hidden,qode-child-theme-ver-1.0.0,qode-theme-ver-10.0,wpb-js-composer js-comp-ver-4.12,vc_responsive

New PRI Funding Collaboration

We are thrilled to support the work of Mesentech, Inc. in a new funding collaborative with CureDuchenne Ventures. Together, our PRI funding will support Mesentech’s pediatric-first approach to developing its bone-targeting therapeutic, which can increase bone mass to strengthen the skeleton and holds promise for a variety of child health conditions.

Access the funding collaborative announcement from CureDuchenne Ventures here and learn more about Mesentech here.